Avinger (NASDAQ:AVGR) Research Coverage Started at StockNews.com

Research analysts at StockNews.com initiated coverage on shares of Avinger (NASDAQ:AVGRGet Free Report) in a report issued on Sunday. The brokerage set a “hold” rating on the medical device company’s stock.

Separately, HC Wainwright reaffirmed a “buy” rating and set a $5.00 price target on shares of Avinger in a research report on Thursday, March 21st.

Check Out Our Latest Research Report on AVGR

Avinger Stock Performance

Shares of AVGR stock opened at $3.04 on Friday. The company has a market capitalization of $5.17 million, a price-to-earnings ratio of -0.12 and a beta of 1.26. Avinger has a 52-week low of $2.50 and a 52-week high of $18.00. The company has a 50-day simple moving average of $3.14 and a two-hundred day simple moving average of $3.73.

Institutional Trading of Avinger

Large investors have recently added to or reduced their stakes in the stock. Renaissance Technologies LLC purchased a new position in Avinger in the second quarter valued at about $42,000. Prosperity Wealth Management Inc. bought a new stake in shares of Avinger in the 2nd quarter worth approximately $49,000. Dimensional Fund Advisors LP purchased a new position in Avinger in the first quarter valued at approximately $64,000. Finally, Armistice Capital LLC grew its holdings in Avinger by 7.8% during the fourth quarter. Armistice Capital LLC now owns 720,136 shares of the medical device company’s stock valued at $781,000 after purchasing an additional 52,000 shares during the period. Hedge funds and other institutional investors own 18.30% of the company’s stock.

About Avinger

(Get Free Report)

Avinger, Inc, a commercial-stage medical device company, designs, manufactures, and sells a suite of image-guided and catheter-based systems used by physicians to treat patients with peripheral artery disease (PAD) in the United States and internationally. It develops lumivascular platform that integrates optical coherence tomography visualization with interventional catheters to provide real-time intravascular imaging during the treatment portion of PAD procedures.

See Also

Receive News & Ratings for Avinger Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avinger and related companies with MarketBeat.com's FREE daily email newsletter.